People with Alzheimer’s disease who took glucosamine were 25% more likely to die within five years than those who didn’t

A joint pain supplement taken by millions of Britons may be linked to an increased risk of dementia, a major new study suggests.

Glucosamine tied to faster progression in people with established neurodegeneration